When to stop?

References

• Silwer L, Johansson E, Stalsby LC. Drug prescribing in public primary care centres: Results from prescription studies 1988–1997 in the county of Halland, Sweden. Scand J Prim Health Care 2000; 20: 236–41
   Google Scholar
• Gaist D. Use and overuse of sumatriptan: Pharmacoepidemiological studies based on prescription register and interview data. Cephalalgia 1999; 19: 735–61
   PubMedGoogle Scholar
• EURO-MED-STAT. Monitoring expenditure and utilization of medicinal products in the European Union countries: A public health approach. Eur J Public Health 2003;13:95–100.
   PubMedGoogle Scholar
• Annual Statistics. Danish Medicines Agency; 2007. Available at: http://dkma.medstat.dk/MedStatDataViewer.php.
   Google Scholar
• Brekke, M, Rognstad, S, Straand, J, Furu, K, Gjelstad, S, Bjørner, T, >, et al. Pharmacologically inappropriate prescriptions for elderly patients in general practice: How common? Scand J Prim Health Care. 2008;26:80–5.
   Google Scholar
• Johnell K, Fastbom J. Multi-dose drug dispensing and inappropriate drug use: A nationwide register-based study of over 700,000 elderly. Scand J Prim Health Care 2008; 26: 86–91
   PubMed Web of Science ®Google Scholar
• Oxford Textbook of Medicine. 4th ed. Oxford University Press: Oxford; 2003.
   Google Scholar
• Harrison's Principles of Internal Medicine. 16th ed. New York: McGraw-Hill; 2004.
   Google Scholar
• Cecil Textbook of Internal Medicine. 22nd ed. Philadelphia: WB Saunders; 2004.
   Google Scholar
• Avery's Drug Treatment. 4th ed. Auckland: Maclennan & Petty; 1997.
   Google Scholar
• Goodman and Gilman's pharmacological basis for therapies. 11th ed. New York: McGraw-Hill; 2005.
   Google Scholar
• Clinical evidence. 2006 ed. London: BMJ Publishing Group; 2006.
   Google Scholar
• Cohen R, Levy C, Boucherat M, Langue J, de La RF. A multicenter, randomized, double-blind trial of 5 versus 10 days of antibiotic therapy for acute otitis media in young children. J Pediatr 1998; 133: 634–9
   PubMed Web of Science ®Google Scholar
• Benador D, Neuhaus TJ, Papazyan JP, Willi UV, Engel-Bicik I, Nadal D, et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: Effect on renal scarring. Arch Dis Child 2001; 84: 241–6
   PubMed Web of Science ®Google Scholar
• East and Central African/British Medical Research Council. Controlled clinical trial of 4 short-course regimens of chemotherapy (three 6-month and one 8-month) for pulmonary tuberculosis. Tubercle 1983;64:153–66.
   PubMedGoogle Scholar
• Joesoef MR, Schmid GP. Bacterial vaginosis: Review of treatment options and potential clinical indications for therapy. Clin Infect Dis 1995; 20: S72–S79
   Google Scholar
• Van Soest EM, Siersema PD, Dieleman JP, Sturkenboom MCJM, Kuipers EJ. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 2006; 24: 377–85
   PubMed Web of Science ®Google Scholar
• Bjornsson E, Abrahamsson H, Simren M, Mattsson N, Jensen C, Agerforz P, et al. Discontinuation of proton pump inhibitors in patients on long-term therapy: A double-blind, placebo-controlled trial. Aliment Pharmacol Ther 2006; 24: 945–54
   PubMed Web of Science ®Google Scholar
• Donnellan, C, Sharma, N, Preston, C, Moayyedi, P. Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease. Cochrane Database Syst Rev 2005;(2):CD003245.
   Google Scholar
• Inadomi JM, Jamal R, Murata GH, Hoffman RM, Lavezo LA, Vigil JM, et al. Step-down management of gastroesophageal reflux disease. Gastroenterology 2001; 121: 1095–1100
   PubMed Web of Science ®Google Scholar
• Reimherr FW, Amsterdam JD, Quitkin FM, Rosenbaum JF, Fava M, Zajecka J, et al. Optimal length of continuation therapy in depression: A prospective assessment during long-term fluoxetine treatment. Am J Psychiatry 1998; 155: 1247–53
   PubMed Web of Science ®Google Scholar
• Viguera AC, Baldessarini RJ, Friedberg J. Discontinuing antidepressant treatment in major depression. Harv Rev Psychiatry 1998; 5: 293–306
   PubMed Web of Science ®Google Scholar
• Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, et al. Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review. Lancet 2003; 361: 653–61
   PubMed Web of Science ®Google Scholar
• Angst J. Fortnightly review. A regular review of the long-term follow up of depression. Br Med J 1997; 315: 1143–6
   PubMedGoogle Scholar
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383–9.
   PubMed Web of Science ®Google Scholar
• Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. N Engl J Med 1998;339:1349–57.
   PubMed Web of Science ®Google Scholar
• Sever PS, Dahlof B, Poulter NR, Wedel H, Beevers G, Caulfield M, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial–Lipid Lowering Arm (ASCOT–LLA): A multicentre randomised controlled trial. Lancet 2003; 361: 1149–58
   PubMed Web of Science ®Google Scholar
• Wei L, Ebrahim S, Bartlett C, Davey PD, Sullivan FM, MacDonald TM. Statin use in the secondary prevention of coronary heart disease in primary care: Cohort study and comparison of inclusion and outcome with patients in randomised trials. Br Med J 2005; 330: 821
   PubMed Web of Science ®Google Scholar
• Gorgels W, Oude Voshaar R, Mol A, Van De Lisdonk E, Mulder J, Van Den Hoogen H, et al. A benzodiazepine discontinuation programme does not increase the frequency of contacts with the family practice. Scand J Prim Health Care 2008; 26: 74–9
   PubMed Web of Science ®Google Scholar